I came across an article on in-Pharma Technologist.com regarding a Stanford University study "described [as] the first-in-man Phase I safety trial of the tobacco-produced vaccines against follicular B-cell lymphoma."
"In an ironic twist, researchers have shown that the tobacco plant, the cause of millions of cases of cancer, can be harnessed to produce personalised cancer vaccines." Full Article here
I really have no comment save that is it more ironic than a fly in your Chardonnay, and it seems as if this might be a real break through for advancing the speed of vaccine growth.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment